Gelteq (GELS) Stock Overview
Focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
GELS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Gelteq Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.86 |
| 52 Week High | US$4.11 |
| 52 Week Low | US$0.77 |
| Beta | 0 |
| 1 Month Change | -18.43% |
| 3 Month Change | -38.24% |
| 1 Year Change | -65.14% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -70.59% |
Recent News & Updates
Shareholder Returns
| GELS | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -3.7% | 1.3% | 1.2% |
| 1Y | -65.1% | 26.1% | 15.8% |
Return vs Industry: GELS underperformed the US Pharmaceuticals industry which returned 26% over the past year.
Return vs Market: GELS underperformed the US Market which returned 15.8% over the past year.
Price Volatility
| GELS volatility | |
|---|---|
| GELS Average Weekly Movement | 12.1% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: GELS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: GELS's weekly volatility has decreased from 37% to 12% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 8 | Nathan Givoni | www.gelteq.com |
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Gelteq Limited Fundamentals Summary
| GELS fundamental statistics | |
|---|---|
| Market cap | US$9.32m |
| Earnings (TTM) | -US$4.46m |
| Revenue (TTM) | US$277.36k |
Is GELS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GELS income statement (TTM) | |
|---|---|
| Revenue | AU$413.13k |
| Cost of Revenue | AU$115.40k |
| Gross Profit | AU$297.74k |
| Other Expenses | AU$6.94m |
| Earnings | -AU$6.65m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.62 |
| Gross Margin | 72.07% |
| Net Profit Margin | -1,608.55% |
| Debt/Equity Ratio | 26.7% |
How did GELS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/26 12:13 |
| End of Day Share Price | 2025/12/26 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Gelteq Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.